Flemington, NJ, United States of America

Daniel Lundell

USPTO Granted Patents = 8 


Average Co-Inventor Count = 6.1

ph-index = 4

Forward Citations = 68(Granted Patents)


Location History:

  • Flemigton, NJ (US) (1998)
  • Flemington, NJ (US) (1998 - 2011)

Company Filing History:


Years Active: 1998-2011

Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: The Innovative Contributions of Daniel Lundell

Introduction

Daniel Lundell is a notable inventor based in Flemington, NJ (US), recognized for his significant contributions to the field of medical treatments. With a total of 8 patents, his work primarily focuses on addressing chemokine-mediated diseases and developing novel therapeutic methods.

Latest Patents

Lundell's latest patents include groundbreaking methods for treating chemokine-mediated diseases. These methods involve the administration of CXC-Chemokine receptor antagonists, which can be combined with other pharmaceutical compounds. The chemokine-mediated diseases targeted by these methods encompass a range of conditions, including acute and chronic inflammatory disorders, psoriasis, cystic fibrosis, asthma, and cancer. Additionally, he has developed isolated human and bovine TNF-α convertases, along with nucleic acids and recombinant vectors encoding these convertases. His inventions also include antibodies that specifically bind to the convertases, which are useful for treating medical conditions caused by TNF-α.

Career Highlights

Throughout his career, Daniel Lundell has worked with prominent companies such as Schering Corporation and Pharmacopeia Drug Discovery, Inc. His experience in these organizations has contributed to his expertise in drug discovery and development.

Collaborations

Lundell has collaborated with notable colleagues, including Charles A. Lunn and Barbara Dalie, enhancing the impact of his research and innovations.

Conclusion

Daniel Lundell's innovative work in the field of medical treatments has led to significant advancements in the understanding and management of chemokine-mediated diseases. His contributions continue to influence the landscape of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…